Public recall detail

Mint-Rosuvastatin Tablet products recall; Out of specification (Impurity)

2025-03-26

medium
Recall Safety notice
Quick summary

Quick summary: Mint-Rosuvastatin Tablet products recall; Out of specification (Impurity). Date: 2025-03-26.

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Mint-Rosuvastatin Tablet products recall; Out of specification (Impurity). Date: 2025-03-26.

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

BrandMint Pharmaceuticals Inc, Mint Pharmaceuticals
ProductMint-Rosuvastatin Tablet
IssueHealth products - Product quality
Recall classType III
IdentificationRA-77183

Affected products

BrandMint Pharmaceuticals
ProductMint-Rosuvastatin 10 mg tablet
DIN / NPN / authorizationDIN 02397803
Dosage formTablet
StrengthRosuvastatin calcium 10 mg
Lot14240935B, 14240936B, 14240937A, 14240934A, 14240935A, 14240936A
BrandMint Pharmaceuticals
ProductMint-Rosuvastatin 20 mg tablet
DIN / NPN / authorizationDIN 02397811
Dosage formTablet
StrengthRosuvastatin calcium 20 mg
Lot14240938A, 14240939A, 14240940A, 14240938B, 14240939B, 14240940B
BrandMint Pharmaceuticals
ProductMint-Rosuvastatin 40 mg tablet
DIN / NPN / authorizationDIN 02397838
Dosage formTablet
StrengthRosuvastatin calcium 40 mg
Lot14240941A, 14240942A

Issue

The Impurity is out of specification in the affected lots.

What you should do

  • Verify if your product is affected.
  • Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  • Contact the recalling firm if you have any questions about the recall.
  • Report any health product related side effects to Health Canada.
  • Report any other health product safety complaints to Health Canada.
Additional official information
AudienceGeneral public Healthcare Industry
CategoryHealth products - Drugs
CompaniesMint Pharmaceuticals Inc 6575 Davand Drive, Mississauga, ON L5T 2M3
Published byHealth Canada
Recall classType III
Alert / recall typeHealth product recall
Identification numberRA-77183
Background{}
CompaniesMint Pharmaceuticals Inc 6575 Davand Drive, Mississauga, ON L5T 2M3
AudiencesGeneral public Healthcare Industry
Source updated2025-03-26

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...